A043710 Stock Overview
SEOULEAGUER Co., Ltd. engages in the healthcare and MSO business in South Korea.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 4/6 |
Dividends | 0/6 |
SEOULEAGUER Co., Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ₩553.00 |
52 Week High | ₩1,062.00 |
52 Week Low | ₩540.00 |
Beta | 1.15 |
1 Month Change | -11.09% |
3 Month Change | -16.97% |
1 Year Change | -30.44% |
3 Year Change | -55.04% |
5 Year Change | -78.61% |
Change since IPO | -98.02% |
Recent News & Updates
Is Seouleaguer (KOSDAQ:043710) A Risky Investment?
Apr 09Here's Why Seouleaguer (KOSDAQ:043710) Can Afford Some Debt
Dec 25Shareholder Returns
A043710 | KR Healthcare | KR Market | |
---|---|---|---|
7D | -5.1% | -0.05% | -2.4% |
1Y | -30.4% | 15.0% | 1.9% |
Return vs Industry: A043710 underperformed the KR Healthcare industry which returned 15% over the past year.
Return vs Market: A043710 underperformed the KR Market which returned 1.9% over the past year.
Price Volatility
A043710 volatility | |
---|---|
A043710 Average Weekly Movement | 3.4% |
Healthcare Industry Average Movement | 5.8% |
Market Average Movement | 5.2% |
10% most volatile stocks in KR Market | 12.0% |
10% least volatile stocks in KR Market | 2.4% |
Stable Share Price: A043710's share price has been volatile over the past 3 months.
Volatility Over Time: A043710's weekly volatility (3%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1991 | 7 | Paek-Chol Kim | www.seouleaguer.net |
SEOULEAGUER Co., Ltd. engages in the healthcare and MSO business in South Korea. The company is involved in pharmaceuticals wholesale and retail; and cosmetics manufacturing and retail businesses. It also provides medical facility operation, and management support project; and offers mobile accessories.
SEOULEAGUER Co., Ltd. Fundamentals Summary
A043710 fundamental statistics | |
---|---|
Market cap | ₩27.76b |
Earnings (TTM) | -₩3.30b |
Revenue (TTM) | ₩22.56b |
1.2x
P/S Ratio-8.4x
P/E RatioIs A043710 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
A043710 income statement (TTM) | |
---|---|
Revenue | ₩22.56b |
Cost of Revenue | ₩21.69b |
Gross Profit | ₩874.12m |
Other Expenses | ₩4.17b |
Earnings | -₩3.30b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -65.67 |
Gross Margin | 3.87% |
Net Profit Margin | -14.61% |
Debt/Equity Ratio | 5.7% |
How did A043710 perform over the long term?
See historical performance and comparison